trans-4,4’-Dihydroxystilbene (DHS) inhibits human neuroblastoma tumor growth and induces mitochondrial and lysosomal damages in neuroblastoma cell lines
SH-SY5Y
MTT assay
Clonogenic assay
DOI:
10.18632/oncotarget.17879
Publication Date:
2017-05-16T10:25:17Z
AUTHORS (7)
ABSTRACT
// Bhaskar Saha 1, 2, * , Birija Sankar Patro 3, 4, Mrunesh Koli 3 Ganesh Pai Jharna Ray 2 Sandip K. Bandyopadhyay 1 and Subrata Chattopadhyay 4 Vijaygarh Jyotish College, Jadavpur, Kolkata 700 032, India S. N. Pradhan Centre for Neuroscience, Ballygunge Science University of Calcutta, 019, Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai 400085, Homi National Institute, Training School Complex, Anushakti Nagar, 400094, These authors have contributed equally to this work Correspondence to: Chattopadhyay, email: schatt@barc.gov.in Keywords: apoptosis, trans -4,4'-dihydroxystilbene, neuroblastoma, lysosomal membrane permeabilization, mitochondrial permeabilization Received: September 09, 2016 Accepted: March 24, 2017 Published: May 16, ABSTRACT In view the inadequacy neuroblastoma treatment, five hydroxystilbenes resveratrol (Resv) were screened their cytotoxic property against human cell lines. The mechanism action most potent compound, -4,4'-dihydroxystilbene (DHS) was investigated in vitro using DHS also tested a mouse xenograft model tumor. MTT, sub-G1, annexin V clonogenic assays as well microscopy established higher cytotoxicity than Resv IMR32 line. (20 μM) induced (MMP) cells, revealed from JC-1 staining, cytochrome c ApaF1 release caspases-9/3 activation. (LMP) cathepsins B, L D, inhibitors partially reduced MMP/caspase-3 ROS, produced by activated p38 JNK MAPKs augment BAX activity BID-cleavage, induce LMP MMP cells. (100 mg/kg) inhibited tumor growth SCID mice 51%. Hence, may be potential chemotherapeutic option neuroblastoma. involvement an independent LMP-dependent is attractive it provides options target both mitochondria lysosome.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (26)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....